Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjunctive vitamin A and vitamin D3 for enhancing allergen-specific immunotherapy efficacy in allergic rhinitis
TCTR20210129003Phase 1Not yet recruiting
- Sponsor
- Department of Medicine, Phramongkutklao Hospital
- Start
- Feb 2021
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of vitamin a and vitamin d in allergic rhinitis (AR) (2 arms), sponsored by Department of Medicine, Phramongkutklao Hospital. Planned start Feb 2021; status: not yet recruiting.
02
Drugs
vitamin avitamin d
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on TCTR20210129003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210129003.